本文選題：老年癡呆 + β-內(nèi)啡肽��； 參考：《中國(guó)老年學(xué)雜志》2017年17期

【摘要】：目的觀察老年癡呆患者血漿β-內(nèi)啡肽濃度的變化及意義。方法將確診為老年癡呆的24例患者隨機(jī)分為治療組和對(duì)照組,每組12例。治療組使用免疫治療,對(duì)照組采用空白對(duì)照。觀察兩組人群2個(gè)月內(nèi)血漿β-內(nèi)啡肽濃度變化。結(jié)果治療前治療組和對(duì)照組血漿β-內(nèi)啡肽水平無(wú)統(tǒng)計(jì)學(xué)差異(P0.05)。經(jīng)過(guò)2個(gè)月的治療,治療組血漿β-內(nèi)啡肽水平顯著低于對(duì)照組(P0.05),治療組6例患者病情有所減輕。結(jié)論降低老年癡呆患者血漿β-內(nèi)啡肽水平可以改善其病情。
[Abstract]:Objective to observe the change and significance of plasma 尾-endorphin in senile dementia patients. Methods 24 patients with Alzheimer's disease were randomly divided into treatment group and control group with 12 cases in each group. Immunotherapy was used in the treatment group and blank control was used in the control group. The changes of plasma 尾-endorphin in two groups were observed within 2 months. Results there was no significant difference in plasma 尾-endorphin levels between the treatment group and the control group before treatment (P 0.05). After 2 months of treatment, the plasma 尾 -endorphin level in the treatment group was significantly lower than that in the control group (P 0.05). Conclusion reducing plasma 尾-endorphin level can improve dementia patients' condition.
【作者單位】： 貴陽(yáng)中醫(yī)學(xué)院;
【分類號(hào)】：R749.16
，

本文編號(hào)：1940619